1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Generic Name | Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
---|---|---|---|
Varenicline | Champix | Smoking cessation aid | 2007/04 |
Vorinostat | Zolinza | Histone deacetylase inhibitor, anti-neoplastic agent | 2009/06/17 |
Velaglucerase alfa | Vpriv | Enzyme replacement for treatment of Gaucher disease | 2010/11/22 |
Vitamin C | Prevegyne | Gynecological antiinfectives and antiseptics | 2011/01 |
Vardenafil | Staxyn | Phosphodiesterase Type 5 Inhibitor | 2011/08/29 |
Vandetanib | Caprelsa | Receptor tyrosine kinase inhibitor (antineoplastic agent) | 2012/01/24 |
Vemurafenib | Zelboraf | Antineoplastic agent | 2012/02 |
Vemurafenib | Zelboraf | Protein kinase inhibitor | 2012/03/06 |
Vortioxetine | Trintellix | Antidepressant | 2014/10/28 |
Vedolizumab | Entyvio | Immunosuppressive agent | 2015/04/21 |
Vilazodone | Viibryd | Antidepressant | 2015/07/16 |
Venetoclax | Venclexta | Antineoplastic agent | 2016/10/31 |
Voretigene | Luxturna | Cellular and gene therapy | 2020/10/13 |